Ventana to Develop CDx for Merck KGaA | GenomeWeb

NEW YORK (GenomeWeb) – Ventana Medical Systems today said that it will collaborate with Merck KGaA on a companion diagnostic test for an undisclosed therapeutic target.

According to the firms, Ventana will develop and validate the CDx test for future clinical studies. Further details of the collaboration were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.